Moderna to report fourth quarter and full year 2022 financial results on thursday, february 23, 2023

Cambridge, ma / accesswire / february 2, 2023 / moderna, inc. (nasdaq:mrna), a biotechnology company pioneering messenger rna (mrna) therapeutics and vaccines, today announced that it will host a live conference call and webcast at 8:00 a.m. et on thursday, february 23, 2023 to report its fourth quarter and full year 2022 financial results, and provide a corporate update.
MRNA Ratings Summary
MRNA Quant Ranking